Private equity investors channeled $151 billion into health care in 2021, up from $79 billion in pre-pandemic 2019. Health care is attractive because of the stability and diversity of the sector, its inefficiency and fragmentation, and the continuous revenue stream from public and private health insurance. From ophthalmology, dermatology, and physician practices to hospice and nursing homes, private equity investments can streamline operations and catalyze innovation. On the flip side, expectations for strong ROI in relatively short time horizons can translate to higher costs and reduced care quality—and regulators have taken notice. Hear from leading investors, providers, and policymakers who are navigating the opportunities and pitfalls in private equity investment and how all are threading the needle to do well for patients and their families.